Dr. Palmer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5777 E. Mayo Boulevard
Phoenix, AZ 85050- Is this information wrong?
Education & Training
- Duke University HospitalFellowship, Hematology and Medical Oncology, 2005 - 2008
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2001 - 2004
- New York Medical CollegeClass of 2001
Certifications & Licensure
- AZ State Medical License 2013 - 2024
- WI State Medical License 2008 - 2013
- NY State Medical License 2003 - 2005
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host Disease Start of enrollment: 2011 Mar 01
- Combined Ruxolitinib and Enasidenib in Patients With Accelerated/Blast-phase Myeloproliferative Neoplasm or Chronic-phase Myelofibrosis With an IDH2 Mutation Start of enrollment: 2021 Jan 14
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Phase 2 study of add-on parsaclisib for patients with myelofibrosis and suboptimal response to ruxolitinib: final results.Abdulraheem Yacoub, Uma Borate, Raajit K Rampal, Haris Ali, Eunice S Wang, Aaron T Gerds, Gabriela Hobbs, Marina Kremyanskaya, Elliott Winton, Casey O'Connell, Swati G...> ;Blood Advances. 2024 Mar 26
- Genetic features and outcomes of allogeneic transplantation in patients with WT1-mutated myeloid neoplasms.Anmol Baranwal, Rami Basmaci, Rong He, Hemant S Murthy, Mehrdad Hefazi, Aref Al-Kali, Hassan B Alkhateeb, Greipp, P., Mangaonkar, A., Viswanatha, D., Foran, J., Palmer...> ;Blood Advances. 2024 Feb 13
- Meaningful Symptomatic Change in Patients With Myelofibrosis From the SIMPLIFY Studies.Hudgens, S., Verstovsek, S., Floden, L., Harrison, C., Palmer, J., Gupta, V., McLornan, D., McMullin, M., Kiladjian, J., Foltz, L., Platzbecker, U., Fox, M., Mead, A.,...> ;Value in Health. 2024 Feb 2
- Join now to see all
Press Mentions
- CTI BioPharma Presents New Anemia Benefit Data from Pacritinib Program at the 2022 American Society of Hematology (ASH) Annual Meeting and ExpositionDecember 11th, 2022
- Pacritinib Approved for Intermediate- or High-Risk Myelofibrosis with ThrombocytopeniaMarch 3rd, 2022
- Fighting Leukemia Then Joining the TeamAugust 2nd, 2019
- Join now to see all
Hospital Affiliations
- Mayo Clinic HospitalPhoenix, Arizona
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: